Business Description:
Epiveris® is an innovative research vertical SaaS solution designed to facilitate global research. It enables adaptation to the pace of change in regulations, data vendors, technology (AI, ML), statistical techniques, study design and related codes. The system enforces tasks, aligns policies, vets phenotyping and data sources, and ensures audit-ready compliance in real time.
Business Description:
Epiveris® is an innovative research vertical SaaS solution designed to facilitate global research. It enables adaptation to the pace of change in regulations, data vendors, technology (AI, ML), statistical techniques, study design and related codes. The system enforces tasks, aligns policies, vets phenotyping and data sources, and ensures audit-ready compliance in real time.
Company Background:
Epiveris® was founded to address a structural problem in healthcare and life sciences: the disconnect between regulatory complexity, fragmented data environments, and operational execution.
Problem:
Healthcare organizations face ever-changing requirements from multiple regulatory bodies, workflows that exist outside the systems driving care, and siloed data sources lacking standardized vetting. Regulatory requirements and clinical protocols are interpreted in silos, phenotyping logic varies, and compliance processes rely heavily on manual interpretation and retrospective documentation.
Solution:
Epiveris® provides a collaborative research platform integrating complex regulations into seamless workflows across regulatory authorities, guidelines, and internal policies. It aligns policies, locks critical tasks, flags gaps in real time, and generates audit-ready evidence, eliminating manual tracking and reactive compliance. It also supports phenotyping data source vetting and protocol development to enable validated analytics and performance improvement.
Markets:
Hospitals, Pharmaceutical, Biotech, Contract Research Organizations, Academia, Government
Management:
Sonja Nakasian, CEO / Co-Founder [email protected]
Paul Richardson, COO / Co-Founder
Justin Barrett, Developer
Mir Ali, Developer
Key Advisors/Board Members:
Dr. Joel Huizenga, Advisor
Dr. Charles Barr, Advisor
Amanda Eldridge, Advisor
